HbA1c (You Later)—What Happens to Glycemic Control while Waiting for NICH?

• DOI: 10.2337/db18-881-p
• Publication Date: 2018-06-22T18:57:35Z
• Authors: DAVID V. WAGNER; RAJKARAN SACHDEJ; NATALIE C. KOSKELA; SAMANTHA A. BARRY; LUZOD HANNAH; ELIZA JAMES-UNREIN; MICHAEL A. HARRIS
• Keywords: 03 medical and health sciences; 0302 clinical medicine; 3. Good health

Objective: Novel Interventions in Children’s Healthcare (NICH) is a community-based, family-focused intervention for youth with T1D who experience self-management difficulty due to social challenges. Previous findings suggest that NICH participation associated improved glycemic control. However, conclusions are limited possibility these outcomes influenced by regression the mean and not reflective of effect. This study examines whether control regresses during wait period following referral NICH. Methods: Youth consistently poor were referred experienced based on insurance approval program capacity. Retrospective chart reviews collected HbA1c values year prior referral, period, Thirty-nine had lab all three time periods. age was 15.4 years; 56% female; 85% Caucasian. Mean days list, 365, 161, 394 days, respectively. Results: Average remained relatively stable wait-period (t(38)=.509, p=.61), going from 11.6 (SD=1.5) 11.5 (SD=1.6). significantly decreased 10.9 (SD=1.6) compared (t(38)=2.31, p=.03) (t(38)=2.30, p=.03). Conclusions: while waiting high, only demonstrating significant clinically meaningful improvement involvement. These that, should always be considered as threat validity, it may apply have history elevated A1cs. Thus, improvements likely represent change their involvement NICH, longer waits access like increase risk short- long-term diabetes complications. Disclosure D.V. Wagner: None. R. Sachdej: N.C. Koskela: S.A. Barry: H. Luzod: E. James-Unrein: M.A. Harris: Consultant; Self; Eli Lilly Company.